Citadel Advisors
SAVAW

Citadel Advisors’s Cassava Sciences, Inc. Warrant SAVAW Stock Holding History

Citadel Advisors’s Portfolio SAVAW Stock Details SAVAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,820
Closed -$193K – 15823
2024
Q1 		$193K Buy
+47,820
New +$286K ﹤0.01% 10379

Other funds holding SAVAW

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's SAVAW Position: Q2 2024 in Review

Citadel Advisors sold out of Cassava Sciences, Inc. Warrant (SAVAW) in Q2 2024, closing a stake of 47,820 shares — an estimated $193K sold.

Citadel Advisors first reported a position in SAVAW in Q1 2024 and held it in 1 quarter. The position peaked at $193K in Q1 2024. 3 funds tracked by Wall St. Rank hold SAVAW as of Q2 2024.

  • Citadel Advisors reported no remaining Cassava Sciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 47,820 Cassava Sciences, Inc. Warrant shares in Q2 2024, an estimated $193K.
  • Citadel Advisors first reported a position in Cassava Sciences, Inc. Warrant in Q1 2024 and held it in 1 quarter.
  • Citadel Advisors's Cassava Sciences, Inc. Warrant position peaked at $193K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Cassava Sciences, Inc. Warrant as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.